Cargando…

Information disclosure of COVID-19 specific medicine and stock price crash risk in China

This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Jiangjiao, Lin, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013702/
https://www.ncbi.nlm.nih.gov/pubmed/35463295
http://dx.doi.org/10.1016/j.frl.2022.102890
_version_ 1784688053139275776
author Duan, Jiangjiao
Lin, Jingjing
author_facet Duan, Jiangjiao
Lin, Jingjing
author_sort Duan, Jiangjiao
collection PubMed
description This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count the keywords occurrence, which derives from a keywords list consisted of “specific medicine”, “vaccine” and others. Based on information disclosure of COVID-19 specific medicine, empirical tests are conducted. The results show that the abnormal COVID-19 disclosure intensifies the degree of stock price crash risk. It proves that information asymmetry exactly exists in listed company information disclosure process in the securities market. It also provides new evidence that exaggerated information disclosure caused stock prices crash.
format Online
Article
Text
id pubmed-9013702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90137022022-04-18 Information disclosure of COVID-19 specific medicine and stock price crash risk in China Duan, Jiangjiao Lin, Jingjing Financ Res Lett Article This study investigates the impact of information disclosure of COVID-19 specific medicine on stock price crash risk. To achieve this goal, crawling massive announcements of listed companies in China and using OCR (optical character recognition) to abstract text, texture analysis is adopted to count the keywords occurrence, which derives from a keywords list consisted of “specific medicine”, “vaccine” and others. Based on information disclosure of COVID-19 specific medicine, empirical tests are conducted. The results show that the abnormal COVID-19 disclosure intensifies the degree of stock price crash risk. It proves that information asymmetry exactly exists in listed company information disclosure process in the securities market. It also provides new evidence that exaggerated information disclosure caused stock prices crash. Elsevier Inc. 2022-08 2022-04-18 /pmc/articles/PMC9013702/ /pubmed/35463295 http://dx.doi.org/10.1016/j.frl.2022.102890 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Duan, Jiangjiao
Lin, Jingjing
Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title_full Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title_fullStr Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title_full_unstemmed Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title_short Information disclosure of COVID-19 specific medicine and stock price crash risk in China
title_sort information disclosure of covid-19 specific medicine and stock price crash risk in china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013702/
https://www.ncbi.nlm.nih.gov/pubmed/35463295
http://dx.doi.org/10.1016/j.frl.2022.102890
work_keys_str_mv AT duanjiangjiao informationdisclosureofcovid19specificmedicineandstockpricecrashriskinchina
AT linjingjing informationdisclosureofcovid19specificmedicineandstockpricecrashriskinchina